EGFR and non-small cell lung carcinoma: Therapy strategies against NSCLC could be classified as chemotherapy, radiotherapy, targeted therapy, and immunotherapy, and targeting therapy of EGFR-tyrosine kinase inhibitors (TKIs) is continuously gaining prominence in research (8).